Colitis ulcerosa: vizsgálatok itt: Magyarország

In Magyarország 18 Also abroad 381

18 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.

2. fázisTaking people
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Where
Budapest, Budapest III, Gyongyos, Szeged, Szekesfehervar
Életkor
18 év and over
People
587 worldwide
Run by
Eli Lilly & Co.
See details and how to join2023-507853-13-00 · EU 2023-507853-13-00
3. fázisTaking people
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Where
Bekescsaba, Budapest
Életkor
18 év and over
People
1380 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06651281 · EU 2024-513533-20-00
2. fázisCsak meghívásos
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Bekescsaba, Budapest III, Budapest VI, Budapest VIII, Szekesfehervar
Életkor
18 év and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
3. fázisTaking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Budapest, Szeged, Szekszárd
Életkor
18 év to 70 év
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
2. fázisTaking people
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Where
Békéscsaba, Budapest, Gyöngyös, Tatabánya, Vác
Életkor
18 év to 80 év
People
252 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07186101
2. fázisTaking people
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Where
Budapest, Gyöngyös, Tatabánya
Életkor
18 év to 80 év
People
1431 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07415044
2. fázisTaking people
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Where
Budapest, Budapest VI, Tatabánya
Életkor
18 év to 80 év
People
60 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07483073 · EU 2025-524112-11-00
3. fázisTaking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Budapest, Budapest III, Budapest VIII, Budapest XIII, Szeged
Életkor
18 év and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
1/2. fázisTaking people
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Where
Budapest, Nyíregyháza, Vác
Életkor
18 év to 75 év
People
270 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06619990
2. fázisTaking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Bekescsaba, Budapest III, Budapest VI, Budapest VIII, Szekesfehervar
Életkor
18 év to 75 év
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
3. fázisTaking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Budapest, Eger
Életkor
16 év to 80 év
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
2. fázisTaking people
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Where
Budapest III, Budapest VIII, Gyongyos, Tatabánya
Életkor
18 év and over
People
104 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-524404-29-00 · EU 2025-524404-29-00
2. fázisTaking people
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Budapest, Debrecen, Gyöngyös, Tatabánya, Veszprém
Életkor
18 év to 75 év
People
204 worldwide
Run by
Palisade Bio
See details and how to joinNCT07845487
3. fázisTaking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Budapest, Veszprém
Életkor
16 év to 80 év
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
2. fázisTaking people
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Where
Bekescsaba, Budapest III, Budapest VIII, Budapest XIII, Gyongyos, Tatabánya, Vac
Életkor
18 év and over
People
75 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522338-30-00 · EU 2025-522338-30-00
2. fázisTaking people
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Budapest VIII, Szeged
Életkor
18 év and over
People
70 worldwide
Run by
Odyssey Therapeutics Inc.
See details and how to join2024-520201-39-00 · EU 2024-520201-39-00
2. fázisTaking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Budapest, Budapest III, Budapest XIII, Mohács
Életkor
18 év to 75 év
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00
3. fázisTaking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Budapest III, Budapest VIII, Miskolc
Életkor
2 év to 17 év
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00